In recent months, measles outbreaks have resurfaced in communities across the United States, a stark reminder that once-controlled infectious diseases can return when immunity gaps grow. While measles is highly contagious, it is also highly preventable.

Across the country, the One Big, Beautiful Bill Act (OBBBA) is making headlines for its impact on research and innovation. Still, one provision matters especially to clinical trial participants: the change in how stipends are reported for tax purposes.

When most people hear the words “clinical trial”, their first thought is often something like, “I don’t want to be a guinea pig.” It’s a natural reaction, after all, the idea of testing new treatments or devices can sound intimidating.